National Bank of Canada’s Cross Country Healthcare CCRN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$119 Buy
+9
New +$107 ﹤0.01% 3001
2023
Q3
Sell
-1,581
Closed -$44.4K 2797
2023
Q2
$44.4K Sell
1,581
-9,475
-86% -$235K ﹤0.01% 1807
2023
Q1
$247K Sell
11,056
-1,078
-9% -$28.2K ﹤0.01% 1358
2022
Q4
$322K Sell
12,134
-3,504
-22% -$114K ﹤0.01% 1356
2022
Q3
$442K Sell
15,638
-445
-3% -$11.4K ﹤0.01% 1191
2022
Q2
$335K Buy
16,083
+12,218
+316% +$229K ﹤0.01% 1285
2022
Q1
$84K Buy
3,865
+3,677
+1,956% +$79.8K ﹤0.01% 1711
2021
Q4
$4K Buy
+188
New +$4.56K ﹤0.01% 2567

Other funds holding CCRN

National Bank of Canada's CCRN Position: Q2 2026 in Review

National Bank of Canada opened a new position in Cross Country Healthcare (CCRN) in Q2 2026: 9 shares worth $119. The stake represents ﹤0.01% of the portfolio and ranks #3001 among its holdings. This is a return to the name: National Bank of Canada previously reported a position in CCRN as recently as Q2 2023.

National Bank of Canada first reported a position in CCRN in Q4 2021 and has held it in 8 quarters since. The position peaked at $442K in Q3 2022. 61 funds tracked by Wall St. Rank hold CCRN as of Q2 2026.

  • National Bank of Canada held 9 shares of Cross Country Healthcare worth $119 as of Q2 2026.
  • Cross Country Healthcare was a new National Bank of Canada position in Q2 2026.
  • Cross Country Healthcare made up ﹤0.01% of National Bank of Canada's portfolio in Q2 2026, its #3001 holding.
  • National Bank of Canada first reported a position in Cross Country Healthcare in Q4 2021 and has held it in 8 quarters since.
  • National Bank of Canada's Cross Country Healthcare position peaked at $442K in Q3 2022.
  • 61 funds tracked by Wall St. Rank held Cross Country Healthcare as of Q2 2026.

Based on National Bank of Canada's 13F filing for Q2 2026, filed 10 Aug 2026.